Tissue_NN
factor_NN
expression_NN
of_IN
human_JJ
monocytes_NNS
is_VBZ
suppressed_VBN
by_IN
lysophosphatidylcholine_NN
._.

The_DT
expression_NN
of_IN
tissue_NN
factor_NN
-LRB-_-LRB-
TF_NN
-RRB-_-RRB-
,_,
the_DT
principal_JJ
initiator_NN
of_IN
coagulation_NN
,_,
is_VBZ
increased_VBN
during_IN
inflammation_NN
and_CC
atherosclerosis_NN
._.

Both_DT
conditions_NNS
are_VBP
promoted_VBN
by_IN
lysophosphatidylcholine_NN
-LRB-_-LRB-
lysoPC_NN
-RRB-_-RRB-
._.

We_PRP
observed_VBD
in_IN
the_DT
present_JJ
study_NN
that_IN
lysoPC_NN
-LRB-_-LRB-
1_CD
to_TO
10_CD
micromol\/L_NN
-RRB-_-RRB-
dose-dependently_RB
reduced_VBD
TF_NN
activity_NN
in_IN
human_JJ
monocytes_NNS
,_,
as_IN
elicited_VBN
by_IN
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
._.

Lysophosphatidylethanolamine_NN
-LRB-_-LRB-
lysoPE_NN
-RRB-_-RRB-
and_CC
other_JJ
lysophospholipids_NNS
did_VBD
not_RB
affect_VB
LPS-induced_JJ
TF_NN
activity_NN
of_IN
human_JJ
monocytes_NNS
._.

TF_NN
antigen_NN
expression_NN
as_IN
elicited_VBN
by_IN
LPS_NN
was_VBD
also_RB
lowered_VBN
by_IN
lysoPC_NN
._.

Phospholipid_NN
analyses_NNS
indicated_VBD
a_DT
selective_JJ
increase_NN
in_IN
the_DT
lysoPC_NN
content_NN
of_IN
the_DT
monocytes_NNS
after_IN
preincubation_NN
with_IN
the_DT
lysophospholipid_NN
._.

LysoPC_NN
inhibited_VBD
the_DT
TF_NN
activity_NN
of_IN
Mono_NN
Mac-6_NN
cells_NNS
to_TO
a_DT
similar_JJ
extent_NN
as_RB
in_IN
the_DT
monocytes_NNS
._.

LPS_NN
binding_NN
to_TO
plasma_NN
membrane_NN
receptors_NNS
and_CC
internalization_NN
of_IN
LPS_NN
into_IN
monocytes_NNS
were_VBD
not_RB
affected_VBN
by_IN
lysoPC_NN
._.

In_IN
contrast_NN
,_,
LPS-mediated_JJ
nuclear_JJ
binding_NN
of_IN
nuclear_JJ
factor-kappaB\/Rel_NN
to_TO
a_DT
TF-specific_JJ
kappaB_NN
site_NN
was_VBD
inhibited_VBN
by_IN
lysoPC_NN
._.

Induction_NN
of_IN
TF_NN
mRNA_NN
expression_NN
by_IN
LPS_NN
tended_VBD
to_TO
be_VB
partially_RB
reduced_VBN
by_IN
the_DT
lysophospholipid_NN
._.

Preincubation_NN
with_IN
lysoPC_NN
increased_VBD
monocytic_JJ
cAMP_NN
levels_NNS
._.

Inhibition_NN
of_IN
adenylyl_NN
cyclase_NN
by_IN
pretreatment_NN
with_IN
2_CD
'_``
-_NN
deoxy-3_JJ
'_''
-_:
adenosine_NN
monophosphate_NN
partially_RB
reversed_VBD
the_DT
inhibition_NN
of_IN
TF_NN
activity_NN
promoted_VBN
by_IN
lysoPC_NN
._.

In_IN
conclusion_NN
,_,
lysoPC_NN
markedly_RB
decreases_VBZ
LPS-mediated_JJ
TF_NN
expression_NN
of_IN
human_JJ
monocytes_NNS
,_,
the_DT
effect_NN
probably_RB
being_VBG
mediated_VBN
by_IN
both_CC
transcriptional_JJ
and_CC
posttranscriptional_JJ
mechanisms_NNS
._.

LysoPC_NN
may_MD
thus_RB
attenuate_VB
activation_NN
of_IN
coagulation_NN
during_IN
inflammation_NN
and_CC
atherosclerosis_NN
._.

